Adverse Drug Reaction Classification System

ADR Ontology
ADR Term T-cell lymphoma
ADR ID BADD_A04228
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.02      Anaplastic large cell lymphomas T- and null-cell types
01.11.02.001      T-cell lymphoma
11      Infections and infestations
11.05      Viral infectious disorders
11.05.17      Retroviral infections
11.05.17.006      T-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.02      Anaplastic large cell lymphomas T- and null-cell types
16.17.02.001      T-cell lymphoma
Description A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. [MeSH]
MedDRA Code 10042971
MeSH ID D016399
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
T-cell lymphoma | T-cell lymphoma NOS | Lymphoma, T-Cell | Lymphoma, T Cell | T-Cell Lymphoma | Lymphomas, T-Cell | T Cell Lymphoma | T-Cell Lymphomas
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine0.000375%
BADD_D00511Clozapine0.001462%
BADD_D00589Dasatinib0.000139%
BADD_D01252Leflunomide0.002066%
BADD_D01253Lenalidomide0.000604%
BADD_D01392Mercaptopurine0.001506%
BADD_D02105Tacrolimus0.000370%
BADD_D02370Vorinostat--
The 1th Page    1    Total 1 Pages